ARREST: rifampicin for Staph. aureus bacteraemia (full length) - a podcast by MRC Clinical Trials Unit at UCL
from 2017-12-15T00:00
::
::
Staphylococcus aureus (S. aureus) bacteraemia is a common infection worldwide, with mortality rates of around 20%, but little research has been done on how best to treat it. This episode explores the results of the ARREST trial, which looked at adding rifampicin to standard antistaphylococcal antibiotic treatment.
Further episodes of MRC CTU Podcasts
Further podcasts by MRC Clinical Trials Unit at UCL
Website of MRC Clinical Trials Unit at UCL